Fowler CJ et al. |
Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. |
2001 |
Biochem. Pharmacol. |
pmid:11585048
|
Moody JS et al. |
Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. |
2001 |
Biochemistry |
pmid:11170406
|
Sugiura T and Waku K |
2-arachidonoylglycerol: an endogenous cannabinoid receptor agonist. |
2001 |
World Rev Nutr Diet |
pmid:11935957
|
Baker D et al. |
Endocannabinoids control spasticity in a multiple sclerosis model. |
2001 |
FASEB J. |
pmid:11156943
|
MacCarrone M et al. |
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. |
2001 |
Eur. J. Biochem. |
pmid:11168423
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Al-Hayani A et al. |
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. |
2001 |
Neuropharmacology |
pmid:11747904
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
Kagota S et al. |
2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. |
2001 |
Eur. J. Pharmacol. |
pmid:11275004
|
Sugiura T et al. |
Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. |
2001 |
Neurosci. Lett. |
pmid:11137756
|
Wang Y et al. |
Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. |
2001 |
Anal. Biochem. |
pmid:11412008
|
Maccarrone M et al. |
Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. |
2001 |
J. Neurochem. |
pmid:11208922
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Savinainen JR et al. |
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. |
2001 |
Br. J. Pharmacol. |
pmid:11588122
|
Suhara Y et al. |
Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11454463
|
Yamaguchi T et al. |
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. |
2001 |
Brain Res. |
pmid:11478928
|
Di Marzo V et al. |
Leptin-regulated endocannabinoids are involved in maintaining food intake. |
2001 |
Nature |
pmid:11298451
|
Wilson RI and Nicoll RA |
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. |
2001 |
Nature |
pmid:11279497
|
Giuffrida A et al. |
Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11408519
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|